[go: up one dir, main page]

NO922304D0 - Eliminering av aktiverte lymfocytter - Google Patents

Eliminering av aktiverte lymfocytter

Info

Publication number
NO922304D0
NO922304D0 NO922304A NO922304A NO922304D0 NO 922304 D0 NO922304 D0 NO 922304D0 NO 922304 A NO922304 A NO 922304A NO 922304 A NO922304 A NO 922304A NO 922304 D0 NO922304 D0 NO 922304D0
Authority
NO
Norway
Prior art keywords
elimination
activated lymphocytes
activated
lymphocytes
octadecylglycero
Prior art date
Application number
NO922304A
Other languages
English (en)
Other versions
NO922304L (no
Inventor
Eberhard Wecker
Anneliese Schimpl
Rabbe Nordstroem
Original Assignee
Medmark Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medmark Pharma Gmbh filed Critical Medmark Pharma Gmbh
Publication of NO922304L publication Critical patent/NO922304L/no
Publication of NO922304D0 publication Critical patent/NO922304D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NO922304A 1989-12-12 1992-06-11 Eliminering av aktiverte lymfocytter NO922304D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3941009A DE3941009A1 (de) 1989-12-12 1989-12-12 Eliminierung von aktivierten lymphozyten
PCT/EP1990/002233 WO1991008746A1 (de) 1989-12-12 1990-12-11 Eliminierung von aktivierten lymphozyten

Publications (2)

Publication Number Publication Date
NO922304L NO922304L (no) 1992-06-11
NO922304D0 true NO922304D0 (no) 1992-06-11

Family

ID=6395316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922304A NO922304D0 (no) 1989-12-12 1992-06-11 Eliminering av aktiverte lymfocytter

Country Status (13)

Country Link
EP (1) EP0505414B1 (no)
JP (1) JPH05504132A (no)
AT (1) ATE102038T1 (no)
AU (1) AU638086B2 (no)
CA (1) CA2071520C (no)
DE (2) DE3941009A1 (no)
DK (1) DK0505414T3 (no)
ES (1) ES2062754T3 (no)
FI (1) FI922710A0 (no)
HU (1) HU217586B (no)
NO (1) NO922304D0 (no)
RU (1) RU2100025C1 (no)
WO (1) WO1991008746A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5517234A (en) * 1993-10-26 1996-05-14 Gerber Systems Corporation Automatic optical inspection system having a weighted transition database
DE19822509A1 (de) * 1998-05-19 1999-11-25 Medmark Pharma Gmbh Edelfosin zur Behandlung von Hirntumoren
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
CA2634349A1 (en) * 2005-12-23 2007-06-28 Jado Technologies Gmbh Means and methods for the treatment and prevention of allergic diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen

Also Published As

Publication number Publication date
CA2071520C (en) 2002-10-01
WO1991008746A1 (de) 1991-06-27
FI922710A0 (fi) 1992-06-11
RU2100025C1 (ru) 1997-12-27
AU638086B2 (en) 1993-06-17
ATE102038T1 (de) 1994-03-15
JPH05504132A (ja) 1993-07-01
HU217586B (hu) 2000-02-28
DK0505414T3 (da) 1994-05-09
DE3941009A1 (de) 1991-06-13
CA2071520A1 (en) 1991-06-13
ES2062754T3 (es) 1994-12-16
AU6954391A (en) 1991-07-18
NO922304L (no) 1992-06-11
EP0505414B1 (de) 1994-03-02
DE59004836D1 (de) 1994-04-07
HUT60927A (en) 1992-11-30
HU9201976D0 (en) 1992-09-28
EP0505414A1 (de) 1992-09-30

Similar Documents

Publication Publication Date Title
DK0435321T3 (da) Nye A-nor-steroid-3-carboxylsyrederivater
EP0261224A4 (en) SYNTHETIC HTLV III PEPTIDE COMPOSITIONS AND THEIR USE.
IT1100477B (it) Procedimento e mezzo per l'espressione microbica di polipertidi
DE3880047D1 (de) Zusammensetzung eines zusatzes.
FI20040479A (fi) 3-aminopiperidiinijohdannaisia ja menetelmiä niiden valmistamiseksi
IT7851783A0 (it) Sistema per l'applicazione di rivetti senza testa
FI833918A (fi) -karboliner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG38163A3 (en) Method for preparing pyrimidones
NO922304L (no) Eliminering av aktiverte lymfocytter
AP8800109A0 (en) "Heterocyclic insecticides".
BG36495A3 (en) Method for preparing 4- quinolic derivatives
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
ES8502092A1 (es) Un procedimiento de resolucion de trans-d1-1-n-propil-6-oxodecahidroquinolina en sus isomeros opticos
FR2454436A1 (fr) Polypeptide synthetique a activite antigenique et procede pour sa preparation
NO792126L (no) Karbazolderivater.
MY104318A (en) Novel thiopen compounds and their preparation
BG38640A3 (en) Method for preparing n- arylsulphenyl- n- diaryloxy- phosphinylmethylglycinates
ATA109689A (de) Brennerplatte eines atmosphaerischen brenners
SU1269465A1 (ru) Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов
IT1245737B (it) Trialchilsilil tetrafluoroetanfosfonati e procedimento per la loro preparazione
SU1417444A1 (ru) 2,4-Дифенил-3(4-ацетокси-4-метилгексин-2-ил)-3-азабицикло [3,3,1]нонан-9-он, проявляющий противовоспалительную активность
BG35329A3 (en) Method for preparing n- phenyl- n- acetyl- 3- amino- oxazolidin- 2- ons
ATE87967T1 (de) Zusammensetzung eines zusatzes.